The Current Ratio as of November 2024 (TTM) for Pulmatrix, Inc. (PULM) is 19.40

According to Pulmatrix, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 19.40. This represents a change of 111.71% compared to the average of 9.16 of the last 4 quarters.

Pulmatrix, Inc. (PULM) Historical Current Ratio (quarterly & annually)

How has PULM Current Ratio performed in the past?

The mean historical Current Ratio of Pulmatrix, Inc. over the last ten years is 5.60. The current 19.40 Current Ratio has changed 34.52% with respect to the historical average. Over the past ten years (40 quarters), PULM's Current Ratio was at its highest in in the December 2014 quarter at 20.47. The Current Ratio was at its lowest in in the March 2018 quarter at 0.33.

Pulmatrix, Inc. (PULM) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Pulmatrix, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pulmatrix, Inc. (PULM) Average Current Ratio

How has PULM Current Ratio performed in the past?

The current Current Ratio of Pulmatrix, Inc. (PULM) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pulmatrix, Inc. (PULM) Current Ratio vs. Peers

How is PULM’s Current Ratio compared to its peers?

Pulmatrix, Inc.’s Current Ratio is greater than Capricor Therapeutics, Inc. (4.19), greater than Akari Therapeutics, Plc (0.29), greater than Diffusion Pharmaceuticals Inc. (10.96), greater than Soleno Therapeutics, Inc. (17.26), less than Onconova Therapeutics, Inc. (0), greater than Catalyst Biosciences, Inc. (1.93), greater than Bio-Path Holdings, Inc. (0), greater than Moleculin Biotech, Inc. (0.86), greater than Bellerophon Therapeutics, Inc. (2.08), greater than Crinetics Pharmaceuticals, Inc. (3.96), greater than Assembly Biosciences, Inc. (16.38), greater than Neoleukin Therapeutics, Inc. (2.36), greater than Instil Bio, Inc. (15.33), greater than CytomX Therapeutics, Inc. (12.90), greater than Achilles Therapeutics plc (1.04), greater than null (6.04),

Build a custom stock screener for Pulmatrix, Inc. (PULM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pulmatrix, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pulmatrix, Inc. (PULM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pulmatrix, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.